We’d like to bring your attention to World Glaucoma Week, March 12–18. This event seeks to spread knowledge about glaucoma’s symptoms, effects, prevention and treatment. The primary message emphasizing the importance of regular eye examinations.

Glaucoma is the second-leading cause of blindness (after cataracts). It’s estimated that that from 11 to 67 million people worldwide suffer from some form of the disease. Glaucoma often develops slowly and painlessly, but the result can be devastating: a gradual but profound loss (narrowing) of the visual field, sometimes culminating in total blindness.

Among the risk factors associated with glaucoma is ocular hypertension— abnormally high pressure within the eye. Study of ocular hypertension in the 1970s led researchers to detect a correlation between cannabis use and a lowering of intraocular pressure in those already diagnosed with glaucoma. While promising, interest in these early experiments waned as other drugs (with more favorable methods of consumption than smoking) proved more effective and long-lasting.

Medical Cannabis and Glaucoma: Research

Advances in studies of the body’s endocannabinoid system (along with now widespread support of cannabis as a medicine) have brought a new level of interest to a link between cannabis compounds and treating glaucoma. We share a few related links here:
Cannabis glaucoma treatment enters phase 1 trials
Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucoma.
Cannabinoids and glaucoma